We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

63 hedge funds and large institutions have $57.7M invested in AVEO Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 15

22% more call options, than puts

Call options by funds: $7.03M | Put options by funds: $5.76M

0% more capital invested

Capital invested by funds: $57.6M → $57.7M (+$59.4K)

3% less funds holding

Funds holding: 65 → 63 (-2)

13% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 15

Holders
63
Holders Change
-2
Holders Change %
-3.08%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
22
Reduced
15
Closed
15
Calls
$7.03M
Puts
$5.76M
Net Calls
+$1.26M
Net Calls Change
-$1.52M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.39M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$409K
3
Northern Trust
Northern Trust
Illinois
+$332K
4
PP
PDT Partners
New York
+$306K
5
State Street
State Street
Massachusetts
+$294K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$1.84M
2
Citadel Advisors
Citadel Advisors
Florida
-$1.79M
3
CAM
Cormorant Asset Management
Massachusetts
-$1.73M
4
6CM
683 Capital Management
New York
-$1.73M
5
MIM
Monashee Investment Management
Massachusetts
-$1.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$6K -$3.55K -718 -40%
Bank of Montreal
52
Bank of Montreal
Ontario, Canada
$6K -$500 -101 -9%
EWM
53
Edge Wealth Management
New York
$6K – – –
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$5K +$40 +8 +1%
UBS Group
55
UBS Group
Switzerland
$4K -$21.4K -4,324 -86%
GWM
56
Geneos Wealth Management
Colorado
$4K +$3.96K +800 New
LFG
57
Larson Financial Group
Missouri
$3K -$9.31K -1,881 -77%
WIM
58
Westside Investment Management
California
$2.97K – – –
Osaic Holdings
59
Osaic Holdings
Arizona
$2K -$495 -100 -23%
AF
60
Advisornet Financial
Minnesota
$1K – – –
FFA
61
Founders Financial Alliance
North Carolina
$1K +$495 +100 New
DM
62
Deerfield Management
New York
– -$1.84M -357,101 Closed
6CM
63
683 Capital Management
New York
– -$1.73M -335,880 Closed
MIM
64
Monashee Investment Management
Massachusetts
– -$1.29M -250,000 Closed
Two Sigma Investments
65
Two Sigma Investments
New York
– -$794K -154,108 Closed
Millennium Management
66
Millennium Management
New York
– -$611K -118,694 Closed
Renaissance Technologies
67
Renaissance Technologies
New York
– -$334K -64,868 Closed
BBVA
68
Banco Bilbao Vizcaya Argentaria
Spain
– -$257K -50,000 Closed
ECM
69
ExodusPoint Capital Management
New York
– -$195K -37,924 Closed
BCM
70
Bridgeway Capital Management
Texas
– -$177K -34,300 Closed
GCP
71
GSA Capital Partners
United Kingdom
– -$172K -33,447 Closed
SAMH
72
Shanda Asset Management Holdings
British Virgin Islands
– -$147K -28,600 Closed
MWNA
73
Marshall Wace North America
New York
– -$147K -28,498 Closed
Two Sigma Advisers
74
Two Sigma Advisers
New York
– -$103K -20,085 Closed
WS
75
Wedbush Securities
California
– -$55K -10,700 Closed
1 2
3
4

AVEO Hedge Fund Activity: Q3 2020 in Review

63 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q3 2020, worth a combined $57.7M — up 0.1% from $57.6M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of AVEO and 13 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 22 added.

The largest buyer was BlackRock, adding an estimated $3.39M. The largest seller was Deerfield Management, exiting entirely with an estimated $1.84M sold.

  • 63 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q3 2020, down from 65 in Q2 2020.
  • Funds reported $57.7M of AVEO Pharmaceuticals, Inc. stock for Q3 2020, up 0.1% quarter-over-quarter.
  • 13 funds opened new AVEO Pharmaceuticals, Inc. positions in Q3 2020 and 15 closed out, a net change of -2 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q3 2020 was BlackRock, an estimated $3.39M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q3 2020 was Deerfield Management, an estimated $1.84M sold.

Based on aggregated 13F filings for Q3 2020.